tradingkey.logo
tradingkey.logo
검색

NeuroOne Medical Technologies Corp

NMTC
관심 목록에 추가
3.000USD
-0.040-1.32%
종가 07/01, 16:00ET시세는 15분 지연됩니다
25.85M시가총액
손실P/E TTM

NeuroOne Medical Technologies Corp

3.000
-0.040-1.32%

자세한 내용은 NeuroOne Medical Technologies Corp 회사

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp 정보

종목 코드 NMTC
회사 이름NeuroOne Medical Technologies Corp
상장일Nov 09, 2012
CEORosa (David A)
직원 수17
유형Ordinary Share
회계 연도 종료Nov 09
주소7599 Anagram Dr
도시EDEN PRAIRIE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호55344-7399
전화19524261383
웹사이트https://nmtc1.com/
종목 코드 NMTC
상장일Nov 09, 2012
CEORosa (David A)

NeuroOne Medical Technologies Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

자주 묻는 질문

NeuroOne Medical Technologies Corp의 상위 5대 주주는 누구인가요?

NeuroOne Medical Technologies Corp의 상위 5대 주주는 다음과 같습니다: Mr. David A. (Dave) Rosa

NeuroOne Medical Technologies Corp(NMTC)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, NeuroOne Medical Technologies Corp의 주식을 보유한 기관은 총 58곳이며, 이들이 보유한 주식의 총 가치는 약 2.36M로 전체 발행 주식의 28.07%를 차지합니다. 이는 2025Q4 대비 -230396.00 증가한 수치입니다.